Avelumab Shows Promise as Frontline Immunotherapy Alternative in NSCLCOncLiveStudy author Claire Verschraegen, MD, who presented the findings at the WCLC, believes that with further research, avelumab could be used as an alternative immunotherapy optio… Continue reading
|
Researchers use stem cells to regenerate the external layer of a human heart
Penn State News UNIVERSITY PARK, Pa. — A process using human stem cells can generate the cells that cover the external surface of a human heart — epicardium cells — according to a multidisciplinary team of researchers. “In 2012, we discovered that if we treated … |
|
Researchers use stem cells to regenerate the external layer of a human heart
Penn State News UNIVERSITY PARK, Pa. — A process using human stem cells can generate the cells that cover the external surface of a human heart — epicardium cells — according to a multidisciplinary team of researchers. “In 2012, we discovered that if we treated … |
Genetic Engineering & Biotechnology News |
Making Stem Cells on a Chip a Reality
Genetic Engineering & Biotechnology News Now a team of researchers from Kyoto University has developed a chip-like plate on which human pluripotent stem cells (hPSCs) can be raised in optimal, three-dimensional (3D) conditions. hPSCs have enormous potential for cell-based therapies, … |
TheStreet.com |
Pharmalot, Pharmalittle: Merck may soon leapfrog rivals in immunotherapy race
STAT The Food and Drug Administration granted priority review for combining Merck’s Keytruda immunotherapy with chemotherapy as an initial treatment for advanced lung cancer. “This comes as an important surprise because if FDA approves the application, … Merck just leapt ahead of its rivals in the lung cancer drug raceBusiness Insider Merck Lung-Cancer Drug May Get OK For Large Patient PopulationInvestor’s Business Daily Speedy review for Merck’s Keytruda/chemo comboPharmaTimes Street Wise Report (press release) (blog) all 20 news articles » |